Compare SUUN & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SUUN | MDAI |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.0M | 47.6M |
| IPO Year | N/A | N/A |
| Metric | SUUN | MDAI |
|---|---|---|
| Price | $1.96 | $1.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $5.00 | $3.25 |
| AVG Volume (30 Days) | ★ 1.1M | 281.6K |
| Earning Date | 02-13-2026 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $32,753,484.00 | $23,168,000.00 |
| Revenue This Year | $127.67 | N/A |
| Revenue Next Year | $4.98 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.23 | $1.04 |
| 52 Week High | $6.43 | $3.25 |
| Indicator | SUUN | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 66.62 | 39.89 |
| Support Level | $1.56 | $1.41 |
| Resistance Level | $2.18 | $1.57 |
| Average True Range (ATR) | 0.18 | 0.09 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 72.50 | 11.59 |
SolarBank Corp is an independent renewable and clean energy project developer, power producer, and asset operator in Canada and the United States, with the majority of its revenue coming from the United States. The Company operates through two reportable segments: Development and EPC, which involves the development and construction of solar photovoltaic power projects, and IPP Production, which includes the operation of solar power and battery energy storage systems. Corporate and other activities cover operation, maintenance, and repairs. The majority of revenue is generated from the Development and EPC segment.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.